Synergizing Radiotherapy and Radioligand Therapy: Optimizing cancer treatment strategies
In this joint GE HealthCare and Elekta lunch symposium, we will explore the emerging synergies between radiation therapy (RT) and radioligand therapy (RLT), focusing on their combined potential to enhance treatment efficacy in oncology.
Welcome: Ilya Gipp, Chief Medical Officer, Oncology Solutions.
Opening remarks: Dr. May May Abdel-Wahab the IAEA
This panel discussion will be focused on:
- the practical considerations for integrating the radiation therapy and radioligand therapy modalities based on the latest clinical evidence, and
optimization strategies.
- patient selection criteria, treatment planning and assessment strategies
- how clinicians can work collectively to improve patient outcomes.
Moderator: Ilya Gipp, MD, PhD, Chief Medical Officer, Oncology Solutions, GE HealthCare
Speakers:
John Christodouleas, Senior Vice President, Medical Affairs and Clinical Research Linac from Elekta
May Abdel-Wahab, MD, PhD, Director of the Division of Human Health (NAHU), International Atomic Energy Agency (IAEA)
Andy Nelson, CEO MIM Software, a GE HealthCare Company
Martina Sollini, MD, PhD Associate Professor in Diagnostic Imaging, Radiotherapy, and Nuclear Medicine
Vita-Salute San Raffaele University
